Professor Sarah Tabrizi (UCL Institute of Neurology) has led a groundbreaking trial, showing the potential for an experimental drug to slow the progression of Huntington's.
Read: Guardian,
More: Independent,
BBC News,
Times (£),
Telegraph,
Reuters,
Huffington Post,
Daily Mail,
Sun,
Metro,
iNews,
Express,
Express (2),
Guardian (2),
CNN,
ABC News,
SBS News,
iNews (2),
Irish Times,
Sun (2),
Al Jazeera,
Fortune,
Radio New Zealand,
Express & Star,
CTV News,
Deutsche Welle,
iNews (3),
Mirror,
New Zealand Herald,
Channel 4 News,
BBC World Service 'The Newsroom' (5 mins 32 secs),
BBC Radio 4 'PM' (from 32 mins 28 secs),
Business Insider,
The Conversation,
Guardian (3),
Guardian (4),
Scientific American
Close
